TRCT
TTHI

Tower Research Capital (TRC)’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Tower Research Capital (TRC)’s Portfolio TTHI Stock Details TTHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-100
Closed – – 5333
2016
Q2 		$0 Sell
100
-1,844
-95% -$1.6K ﹤0.01% 5609
2016
Q1 		$2K Buy
1,944
+498
+34% +$575 ﹤0.01% 3610
2015
Q4 		$3K Buy
1,446
+946
+189% +$1.8K ﹤0.01% 3658
2015
Q3 		$1K Buy
+500
New +$1.06K ﹤0.01% 3883
2015
Q2 		– Sell
-100
Closed -$1K – 5770
2015
Q1 		$1K Sell
100
-101
-50% -$698 ﹤0.01% 4337
2014
Q4 		$1K Buy
+201
New +$1.3K ﹤0.01% 3914
2014
Q2 		– Sell
-860
Closed -$7K – 5460
2014
Q1 		$7K Sell
860
-168
-16% -$1.16K ﹤0.01% 3062
2013
Q4 		$6K Buy
1,028
+988
+2,470% +$5.06K ﹤0.01% 3485
2013
Q3 		$0 Buy
+40
New +$157 ﹤0.01% 5349

Other funds holding TTHI

HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Tower Research Capital (TRC)'s TTHI Position: Q3 2016 in Review

Tower Research Capital (TRC) sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 100 shares.

Tower Research Capital (TRC) first reported a position in TTHI in Q3 2013 and held it in 9 quarters. The position peaked at $7K in Q1 2014. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • Tower Research Capital (TRC) reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016.
  • Tower Research Capital (TRC) first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q3 2013 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s TRANSITION THERAPEUTICS INC (CANADA) position peaked at $7K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.